PAMU
ENZN

Pictet Asset Management (UK)’s ENZON PHARMACEUTICALS INC ENZN Stock Holding History

Pictet Asset Management (UK)’s Portfolio ENZN Stock Details ENZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-316,200
Closed -$329K – 900
2014
Q2 		$329K Hold
316,200
– – ﹤0.01% 835
2014
Q1 		$326K Hold
316,200
– – ﹤0.01% 832
2013
Q4 		$367K Buy
+316,200
New +$487K ﹤0.01% 825

Other funds holding ENZN

IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 39.77% 1-Year Est. Return
CSC
Cove Street Capital El Segundo, California $76.6M AUM 36% 1-Year Est. Return
U
UBS Zurich, Switzerland $136B AUM 16.35% 1-Year Est. Return

Pictet Asset Management (UK)'s ENZN Position: Q3 2014 in Review

Pictet Asset Management (UK) sold out of ENZON PHARMACEUTICALS INC (ENZN) in Q3 2014, closing a stake of 316,200 shares — an estimated $329K sold.

Pictet Asset Management (UK) first reported a position in ENZN in Q4 2013 and held it in 3 quarters. The position peaked at $367K in Q4 2013. 65 funds tracked by Wall St. Rank hold ENZN as of Q3 2014.

  • Pictet Asset Management (UK) reported no remaining ENZON PHARMACEUTICALS INC position as of Q3 2014 after selling out during the quarter.
  • Pictet Asset Management (UK) sold 316,200 ENZON PHARMACEUTICALS INC shares in Q3 2014, an estimated $329K.
  • Pictet Asset Management (UK) first reported a position in ENZON PHARMACEUTICALS INC in Q4 2013 and held it in 3 quarters.
  • Pictet Asset Management (UK)'s ENZON PHARMACEUTICALS INC position peaked at $367K in Q4 2013.
  • 65 funds tracked by Wall St. Rank held ENZON PHARMACEUTICALS INC as of Q3 2014.

Based on Pictet Asset Management (UK)'s 13F filing for Q3 2014, filed 12 Nov 2014.